Clinical trial · Observational
Results of CRS and Debulking in PMP Patients
Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei
NCT01427101CI-TRIAL-00005435unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pseudomyxoma Peritonei | Pseudomyxoma Peritonei | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival
- description
- from treatment and forward
Secondary outcomes (1)
- measure
- morbidity and mortality
- timeFrame
- 90 days
- description
- mortality is messured during the first 90 postoperative days and morbidity during hospital stay.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with radiology histopathology finding of Pseudomyxoma Peritonei Exclusion Criteria: * Preformance status WHO \>2 and histopathology shows other origin then Pseudomyxoma Peritonei
References
Publications (0)
Data not yet available
No reference posted for this study.